Introduction
Plasma factor XIII (pFXIII) is a zymogen consisting of two catalytic A subunits (FXIII-A) exerting a transglutaminase activity upon its activation, and two inhibitory B subunits (FXIII-B). FXIII-A is expressed primarily in cells of bone marrow origin, but it is not fully understood how FXIII-A is released from the cellular compartments. FXIII-B is a qlycoprotein synthesized and secreted by hepatocytes as a result of excessive plasma levels of FXIII-A [1] [2] [3] .
FXIII-A is a blood coagulation proto-transglutaminase, which becomes activated in the last stage of the clotting cascade as a result of the concerted action of thrombin and Ca
2+
. The key haemostatic function of FXIII-A is fibrin stabilization by cross-linking fibrin chains and covalently attaching to the main inhibitor of plasmin, α2-plasmin inhibitor (α2PI). FXIII-A activity considerably enhances fibrin stiffness and rigidity and makes it more resistant against shear stress. The stabilization effect of the FXIII-A has the predominant role in protecting newly formed fibrin from elimination by plasmin. The importance of these haemostatic mechanisms is underlined by severe bleeding diathesis of FXIII-A deficient patients [4] .
In addition to the functional haemostatic role in blood coagulation cascade, FXIII-A's role is significant to multiple extra-and intracellular functions. FXIII-A, as a potential active subunit is also present in the cytoplasm of platelets, monocytes, macrophages, dendritic cells, chondrocytes, osteoblasts, and osteocytes. It can be detected from the early stage of monoblasts in the bone marrow via blood monocytes to the connective tissue macrophages [4] [5] [6] [7] [8] [9] [10] [11] . FXIII-A is considered as a positive marker protein of the cell line in which it acts as an intracellular transglutaminase with roles in various intracytoplasmatic and intranuclear processes. The role of intracellular FXIII-A in platelets, monocytes, macrophages, and other inflammatory cells is an open and widely discussed question. It was suggested that this factor is involved in intracellular presentation, distribution, and other possible activation of cells' secretion [2, 6] .
In healthy skin FXIII-A is confined to the dermis, with greater expression within the papillary dermis, at the dermo-epidermal junction, and in loose areolar connective tissue around the cutaneous appendages [12] . It is also used as a diagnostic marker in various dermatological diseases ranging from inflammatory lesions such as psoriasis, eczema, spongiotic dermatoses, lichen planus, toxic epidermal necrolysis, and uricaria, to malignancies such as dermatofibromas, Kaposi's sarcomas, basal cell carcinomas and malignant melanomas [4, 10, [12] [13] [14] [15] [16] [17] [18] [19] ].
FXIII-A in inflammatory processes
There is information about the relationship between polymorphonuclear (PMN) leukocytes and the activation of FXIII-A. The activated inflammatory PMN leukocytes are the main source of human neutrophile elastase (HNE), cathepisn G and metalloproteinases, which are secreted upon their activation. This hypothesis was confirmed in studies demonstrating that HNE induced a cleavage of pFXIII or cellular dimeric form of XIII-A and resulted in their catalytic effect activation. It was also suggested that HNE-activated FXIII-A was responsible for cross-linking fibrin γ-, and α-chains. HNE-activated FXIII-A stabilize fibrin tissue deposits, the persistence of which is a hallmark of many acute and chronic inflammatory diseases [6, 20] .
The effect of active FXIII-A on leukocytes is an additional aspect of their interactions. It is suggested that activated FXIII-A improved the proliferation of peripheral blood leukocytes, accelerated their migration, and significantly reduced their apoptosis rate, leading to the development of the inflammatory infiltrate [6, 20] . The association of the enhanced cell proliferation and survival induced by FXIIIa with the down-regulation of thrombospondin-1 (TSP-1) and up-regulation of c-Jun and early growth response protein 1(Egr-1) was observed [21] .
Another interesting aspect of the indirect relationship between FXIII-A and macrophages concerns the FXIII-A related generation of monocyte chemotactic factor. In a recent study it was shown that a plasma protein with the features of ribosomal protein S19, is dimerized by FXIIIa and converted into a monocyte-selective chemoattractive factor [8, 22] . Such monocyte specific chemotactic factors related to activated FXIII-A could be involved in recruiting monocytes and in the development of inflammatory infiltration.
Fibrin derivatives are involved in inflammatory processes and the generation of a stable fibrin network is necessary for sufficient inflammation control. The density and stability of fibrin networks depend on FXIIIA. In the study conducted by Hopped et al. [23] , FXIII-A gene variants modulating inflammation by influencing fibrin crosslinking were identified. These haemostatic gene variants as novel genetic determinants of C-reactive protein (CRP) in inflammatory process were considered.
The expression of FXIII-A specific mRNA in a number of monocyte-derived macrophages including tumor macrophages, histocytes, dendritic reticulum cells, perivascular dendritic macrophages, and dermal dendrocytes was demonstrated, and their responsibility for the FXIII-A synthesis was strongly suggested [6, 8, 12, 15, [22] [23] [24] [25] . It was also observed that induction of monocytes differentiation into antigen presenting dendritic cells resulted in highly elevated FXIII-A expression, and its crucial role by fibrin crosslinking in this transformation was suggested. The majority of macrophages in granulomas of sarcoidosis and tuberculosis are negative for FXIII-a, that fact indicates that the induction of the classical activation pathway by interferon γ (IFN-γ) or interleukin 6 (IL-6) down-regulated FXIII-A mRNA and protein expression in cultured macrophages. In the same study, it was suggested that up-regulation of the FXIII-A in macrophages indicates its activation on the alternative pathway induced by the interleukin 4 (IL-4) and interleukin 13 (IL-13) [26] . IL-4 with granulocyte/macrophage-colony stimulating factor (GM-CSF) is also involved in the expression of high levels of FXIII-A mRNA and induction of monocytes differentiation into antigen-presenting dendritic cells present in tissue, like subsets of dermal dendrocytes in inflammatory response. FXIII-A as an indirect marker of the alternative macrophage activation pathway suggests that FXIII-A-positive macrophages play an important role in conditions where extracellular remodeling is the key feature. The current microarray technique analysis show that alternatively activated human macrophages FXIII-A-positive were involved in the regulation of gene expression leading to the most prominent differences in immunological protein activity [1, 6] . Intracellular functions of FXIII-A in monocytes and macrophages in few studies were concerned, suggesting that FXIII-A has significant involvement in the inhibition mechanism of phagocytosis activity. In another report the intracellular role of FXIII-A in cell locomotion of dendritic cells was observed. As both phagocytosis and cell migration involve in intracellular contractile elements, the relationship between cytoplasmic FXIII-A and cytoskeletal components seems feasible [1, 6, 20 ].
FXIII-A in inflammatory skin lesions
Inflammatory skin dermatoses are a heterogeneous group of entities which manifestation and progression are driven by the interaction of multiple genetic as well as environmental factors. In recent studies the role of FXIII-A as a potential modulator factor in development of inflammatory process was indicated [1, 4, 6, 9, 12, 15] .
Generally, FXIII-A-positive cells in pathological skin lesions can be divided into expression in inflammatory, fibrosis, and in neoplastic pathology. Inflammatory macrophages may release or express FXIII-A and take a crucial role in the development and course of inflammation processes in dermis (Figure 1) . The important role assigned to FXIII-A in inflammation is related to the fact that several adhesive glycoproteins are transglutaminase substrates. The FXIII-A related enzymes may play an important role in formation of inflammatory infiltration, by modulation of cell adhesion and migration. The role of FXIII-A in inflammatory skin lesions is important with wide-range interactions but still remains not-fully understood. The reaction catalyzed by activated FXIII-A influence the structural integrity and tensegrity of FXIII-A-positive dermal dendritic cellrich tissues. Change in the FXIII-A-positive dermal dendrocytes is characterized by intense cytoskeletal reorganization resulting in many cellular functions and improvement of tensegrity. The intracellular activity of FXIII-A may be responsible for proliferation, differentiation, migration, survival and excessive inflammatory cytokine secretion of dermal dendrocytes [5, 6, 8, 9, 12, 15] .
The elevated dermal expression of FXIII-A in the inflammatory skin diseases such as psoriasis, eczema, spongiotic dermatoses, lichen planus, toxic epidermal necrolysis, and uricaria was observed [4, 10, [12] [13] [14] [15] [16] [17] [18] [27] [28] [29] . Migration of FXIII-A-positive inflammatory macrophages and dermal dendrocytes in association with other inflammatory cells into the epidermal compartment in chronic plaque psoriasis was reported. It was postulated that FXIII-A dermal dendrocytes play a significant role in skin lymphocyte locomotion through tumor necrosis factor alpha (TNF-α) as the main proinflammatory cytokine, which suggests a crucial role of factor in formation of the psoriasis skin lesions. The FXIII-A-positive dermal dendrocytes may proceed to development of psoriasis via TNF-α, which stimulates keratinocyte to produce interleukin 8 (IL-8) and to express ICAM. In acute and chronic graft-versushost disease (GVHD), high dermal levels of FXIII-A were observed [17] . Also observed was the migration of FXIII-A-positive cells from the papillary dermis into the epidermis in close proximity to lymphocytes, macrophages and other inflammatory cells in inflamed skin of atopic eczema or psoriasis [8, 29] .
The study conducted by Journdosson et al. [27] found that FXIII-A dermal dendrocytes in the elicitation phase of contact hypersensitivity constitute a major accessory cell population in the dermis. The role of FXIII-A in antigen presentation and its relationship to the expression of antigen presenting molecules CD1 and MHC II were suggested. Other studies showed that FXIII-A is considered as a positive disease-nonspecific marker of skin lesions with a possible common mechanism of dermal dendrocytes, macrophages, lymphocytes and plasma activity [14, 19, 30] .
In conclusion, FXIII-A plays a significant, widerange, but not-fully understood role in the development of inflammatory skin disorders. Factor XIII-A participates in multiple effects in dermis by plasmatic signal factor, clotting cascade, and extra-and intracellular acting on inflammatory cells. Factor XIII-A level may be used in diagnosis and could become the prognostic indicator of exacerbations and remissions in chronic inflammatory skin diseases. Further studies on the FXIII-A pathomechanism may facilitate diagnostic procedures and treatment.
